Nationwide Research on the Rewilding of Kindergarten Yards

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-5
SponsorNatural Resources Institute Finland

About this trial

Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities that is associated with altered commensal microbiota and a rising burden of immunological disorders among urban children.

The investigators will estimate how rewilding of kindergarten yards affects commensal microbiome, prevalence of allergies, asthma, atopic dermatitis and infections, cortisol levels, cognitive skills and plasma cytokine levels of children.

Our specific aims are:

To assess if rewilding diversifies health-associated skin, saliva and gut microbiota and reduces infectious diseases and atopic or allergic symptoms.

Assess whether the rewilding has positive effects on cognitive skills. Assess whether the rewilding changes cortisol and plasma cytokine levels. The investigators will recruit altogether 320 (160 per treatment) study subjects aged between 1-5 to questionnaire study (Task 2), from which 120 study subjects will be analyzed more detailed using microbiological and blood samples (Task 1).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Attendance in kindergarten

Disqualifiers

Use of antibiotics in the year before sampling

Trial design

Design model

Parallel

Treatments tested in this trial

  • Biodiversity

    Other intervention

    In rewilding kindergartens, the yards are modified with biological elements, i.e., vegetation and plantation will be added to the yards.

  • Playground equipment

    Other intervention

    Playground equipment that increase the physical activity of children will be added to the kindergarten yards.

Treatment groups

320 Participants
are divided into 2 treatment groups
Group A: RewildingExperimental treatment 1 intervention
Group B: ControlExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Skin Gammaproteobacteria

Difference on skin gammaproteobacterial diversity between rewilding and control group

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year

Secondary outcomes

1

Cortisol levels

Cortisol levels measured from hair samples

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year
2

Difference in diversity of skin, saliva and stool microbiota

It will be analyzed if microbial communities are different between treatments

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year
3

Microbial observed species richness

Higher score in observed species richness of commensal microbiota among biodiversity treatment

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year
4

Difference in taxonomies of skin, saliva and stool microbiota

It will be analyzed if microbial communities are different between treatments

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year

Other outcomes

1

Associations between environmental factors and cytokine levels.

It will be analyzed if environmental factors correlate with cytokine levels.

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year
2

Associations between environmental factors and commensal microbiota.

It will be analyzed if environmental factors correlate with richness of commensal microbiota.

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year
3

Associations between environmental factors and white blood cells

It will be analyzed if environmental factors correlate with white blood cell distributions.

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year
4

Associations between environmental factors and cortisol levels

It will be analyzed if environmental factors correlate with cortisol levels.

Time frame
Baseline, 3 month, 1 year, 2 year, 3 year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.